Apr 25, 2019 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $15.14, marking a +0.93% move from the previous day.
Apr 24, 2019 - Teva's share price has continued to sell-off in 2019 under the weight of the company's debt and shrinking revenue.The stock's current valuations point towards a value buy while the charts point toward
Apr 22, 2019 - Shelter Ins Retirement Plan Buys Activision Blizzard Inc, Sells Franklin Resources Inc, Teva Pharmaceutical Industries, Stocks: ATVI,BEN,TEVA,, release date:Apr 22, 2019
Apr 22, 2019 - Shelter Mutual Insurance Co Buys Activision Blizzard Inc, Sells Franklin Resources Inc, Teva Pharmaceutical Industries, Stocks: ATVI,BEN,TEVA,, release date:Apr 22, 2019
Apr 20, 2019 - The FDA grants final approval for Teva Pharmaceutical Industries' (NYSE:TEVA) generic version of Adapt Pharma's NARCAN Nasal Spray (naloxone HCl), an opioid reversal agent designed to be used by someo
Apr 16, 2019 - Teva has struggled ever since its mistimed an ill-conceived acquisition of Actavis Generics.The generic drug market is finally bottoming out and Teva is poised to benefit as this market recovers in a
Apr 11, 2019 - BioDelivery Sciences (BDSI) announces acquisition of U.S. commercial rights to pain drug, Symproic, from Japanese company, Shinogi.
Apr 09, 2019 - Good bargains are hard to find in today's market. Here are a few overlooked stocks for you to capitalize on.
Apr 05, 2019 - Novartis (NVS) announces plans to acquire IFM Tre, a subsidiary of IFM Therapeutics focused on anti-inflammatory drugs. Pfizer (PFE) & Teva's (TEVA) drugs get regulatory approvals in EU.
Apr 05, 2019 - Oklahoma's attorney general dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical in a closely watched lawsuit alleging the drugmakers helped fuel the U.S. opioid epidemic.